A new editorial paper was published in Oncoscience (Volume 10) on June 9, 2023, entitled, “Transforming early cancer detection in primary care: harnessing the power of machine learning.”
Cancer remains a significant global health burden, and early detection plays a crucial role in improving patient outcomes.
Primary care settings serve as frontline gatekeepers, providing an opportunity for early detection through symptom assessment and targeted screening.
However, detecting early-stage cancer and identifying individuals at high risk can be challenging due to the complexity and subtlety of symptoms.
The challenging nature of early detection is revealed by diagnostic errors in primary care, with cancer being one of the most frequently missed or delayed diagnoses.
In recent years, the emergence of machine learning (ML) techniques has shown promise in revolutionising early detection efforts.
In this new editorial, researchers Elinor Nemlander, Marcela Ewing, Axel C. Carlsson, and Andreas Rosenblad from Karolinska Institutet and the Academic Primary Health Care Centre at Region Stockholm explore the potential of ML in enhancing early cancer detection in primary care.
“ML has the potential to transform early cancer detection in primary care by leveraging extensive patient data and improving risk stratification and pre-diagnostic accuracy, hopefully saving lives. However, responsible and equitable implementation of ML models requires careful attention to ethical considerations, collaboration, and validation across diverse populations.”
Source: Impact Journals LLC
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.